The chart below shows how TTMI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, TTMI sees a +1.79% change in stock price 10 days leading up to the earnings, and a +6.40% change 10 days following the report. On the earnings day itself, the stock moves by +0.32%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Earnings Per Share Beat: TTM Technologies reported a Q4 2024 EPS of $0.60, exceeding expectations of $0.47, reflecting strong financial performance.
Q4 Revenue Surge: Revenues for Q4 2024 reached $651 million, a 14% increase year-on-year, marking the fourth consecutive quarter of revenue growth driven by Aerospace and Defense and Data Center Computing markets.
Aerospace and Defense Sales Growth: The Aerospace and Defense segment represented 47% of total sales in Q4 2024, with revenues growing 16% year-on-year to an all-time record high, supported by a strong program backlog of approximately $1.56 billion.
EBITDA Improvement Analysis: Adjusted EBITDA for Q4 2024 was $108.7 million, or 16.7% of net sales, compared to $80.9 million, or 14.2% of net sales in Q4 2023, indicating improved operational efficiency.
Strong Cash Flow Performance: Cash flow from operations in Q4 2024 was robust at $86.1 million, representing over 13% of net sales, contributing to a strong cash position of $503.9 million at the end of the quarter.
Negative
Operating Income Decline: GAAP operating income for Q4 2024 was $9 million, a significant decline from $34.6 million in Q4 2023, primarily due to a $32.6 million goodwill impairment charge.
Net Income Decline: Net income for Q4 2024 was $5.2 million or $0.05 per diluted share, down from $17.3 million or $0.17 per diluted share in Q4 2023, reflecting a substantial decrease in profitability.
Gross Margin Decline: Gross margin decreased to 20.5% in Q4 2024 from 21.3% in Q4 2023, attributed to higher employee-related costs and ongoing start-up costs in Penang.
Medical Instrumentation Revenue Decline: The Medical Industrial Instrumentation end market saw a 9% decline in full-year revenues due to continued inventory corrections, with Q4 sales contributing only 13% of total sales compared to 16% in the prior year.
Automotive Sales Decline: Automotive sales dropped 12% for the full year 2024, with Q4 representing only 11% of total sales, impacted by inventory adjustments and weak demand as EV growth stalled.
TTM Technologies, Inc. (NASDAQ:TTMI) Q4 2024 Earnings Call Transcript
TTMI.O
-1.99%